New liquid-handling corporate brand
INTEGRA Biosciences AG has announced that as a result of the recent merger with Viaflo the two companies will adopt a new corporate brand - INTEGRA.
INTEGRA Biosciences AG has announced that as a result of the recent merger with Viaflo the two companies will adopt a new corporate brand - INTEGRA.
"The recent merger between Integra Biosciences AG of Switzerland and Viaflo Corporation of the US has created a strong corporate entity that develops, manufactures, sells and services a wide variety of innovative laboratory products to over 90 countries” said Elmar Morscher, the CEO of Integra Biosciences, in a statement.
“The focal point of the combined worldwide business is liquid-handling solutions; both represented as instrumentation and consumables designed primarily for the life sciences marketplace. The wide range of complimentary products produced by the two companies, along with numerous exciting new product additions planned for 2010, will be repositioned under the new corporate brand INTEGRA.
“The INTEGRA brand will replace existing brands within the combined businesses and will represent a clear direction of a company that has merged the best of the old with a singular and simple goal of producing new innovative and high value liquid-handling products for the future."
A website for the brand has been set up, it incorporates the complete range of products from both companies, provides visitors with direct access to a source of information and news and provides rapid access to an expanding applications database and scientific reports bibliography.
The website is www.integra-biosciences.com
An LC–HRMS Method for Separation and Identification of Hemoglobin Variant Subunits
March 6th 2025Researchers from Stanford University’s School of Medicine and Stanford Health Care report the development of a liquid chromatography high-resolution mass spectrometry (LC–HRMS) method for identifying hemoglobin (Hb) variants. The method can effectively separate several pairs of normal and variant Hb subunits with mass shifts of less than 1 Da and accurately identify them in intact-protein and top-down analyses.
The Next Frontier for Mass Spectrometry: Maximizing Ion Utilization
January 20th 2025In this podcast, Daniel DeBord, CTO of MOBILion Systems, describes a new high resolution mass spectrometry approach that promises to increase speed and sensitivity in omics applications. MOBILion recently introduced the PAMAF mode of operation, which stands for parallel accumulation with mobility aligned fragmentation. It substantially increases the fraction of ions used for mass spectrometry analysis by replacing the functionality of the quadrupole with high resolution ion mobility. Listen to learn more about this exciting new development.
